Celerion

Celerion is a global leader in early clinical research, providing comprehensive services to the pharmaceutical and biotechnology industries. Originally founded in 1933 as Harris Laboratories, the company transitioned to healthcare-focused clinical research by 1969. Celerion was established in 2010 through the acquisition of MDS Pharma Services' early-stage development operations, continuing a legacy of over 80 years in clinical research. The company specializes in early-stage clinical trials, including first-in-human studies and proof-of-concept trials. Celerion also offers bioanalytical testing, drug development consultancy, and medical writing services. With corporate headquarters in Lincoln, Nebraska, and facilities across North America, Europe, and Asia, Celerion operates over 750 beds and employs around 950 staff. The company has conducted over 6,000 clinical studies across various therapeutic areas, supporting clients in making informed decisions to advance investigational medicines from development to market approval. Celerion is committed to community engagement and workforce development, fostering local talent in biotechnology and bioanalysis.